About
This business case has been created so that each organisation can assess the potential for improvements in the identification and management of Atrial Fibrillation (AF) in four key areas:
- Diagnosis of AF
- - Detection Gap
- Identification of those at high risk of stroke (CHA2DS2-VASc):
- - Protection Gap 1 (no risk assessment)
- Initiation of anticoagulant therapy in line with national guidelines
- - Protection Gap 2 (eligible and untreated)
- Maintenance of adequate anticoagulation:
- - Perfection Gap